60 keV准单能汇聚光子的放射生物学特征
研究比较了60 keV准单能汇聚光子、180 kVp正交电压(平均能量约60 keV)与6 MV临床光子对肺癌细胞及正常支气管上皮细胞的生物学效应,并采用NCI-H460异种移植模型评估体内肿瘤生长延迟。结果显示,60 keV汇聚光子与正交电压光子效果相似,对部分细胞系杀伤和RBE高于6 MV光子,体内抑瘤效果与6 MV光子相当。
要点
- 60 keV汇聚光子对3种细胞系的杀伤和RBE与6 MV光子相当。
- 对NCI-H460细胞杀伤和RBE显著高于6 MV光子,NCI-H2172不显著。
- NCI-H460异种移植模型中,60 keV汇聚光子显著延迟肿瘤生长,效果与6 MV光子相当。
核心结论
- 体外和体内评估证实60 keV准单能汇聚光子的生物学效应与正交电压(平均能量约60 keV)光子相似。
- 与6 MV光子相比,60 keV汇聚光子在3种细胞系中效果相当,在2种细胞系中更高但其中1种不显著。
研究设计与样本
- 研究使用人肺癌细胞系NCI-H460和NCI-H2172、鼠肺癌细胞系KLN-205和LKR-13以及正常人支气管上皮细胞系Beas-2B。
- 细胞接受6 MV直线加速器光子、180 kVp正交电压(平均能量约60 keV)或60 keV准单能汇聚光子照射。
- 采用克隆形成细胞存活分析评估剂量反应指标和相对生物学效应(RBE),并在人源肺癌细胞系中评估DNA损伤和细胞周期。
- 采用NCI-H460人肺癌异种移植模型测试体内肿瘤生长延迟。
主要发现
- 相对于6 MV光子,60 keV汇聚光子和正交电压光子对LKR-13、KLN-205和Beas-2B细胞系的杀伤效应和RBE相当。
- 对NCI-H460细胞系杀伤效应和RBE更高且显著,对NCI-H2172细胞系更高但不显著。
- NCI-H460细胞对正交电压和60 keV汇聚光子的增强生物学反应还表现为DNA损伤信号增加和细胞周期检查点激活。
- 即使同一辐射类型,不同细胞系的放射敏感性差异也相当大。
- 在NCI-H460异种移植模型中,60 keV汇聚光子显著延迟肿瘤生长,效果与6 MV光子相当。
临床怎么用
- 60 keV准单能汇聚光子在体外和体内模型中表现出与正交电压光子相似的生物学效应。
- 对部分肺癌细胞系,其杀伤效应和RBE可能高于6 MV光子,但需注意细胞系间差异。
- 体内抑瘤效果与6 MV光子相当,支持进一步临床前评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To characterize the biological effects of low-energy photons generated by a ∼60-keV quasimonoenergetic focused convergent-beam system (patented x-ray converging lens) compared with orthovoltage and 6-MV clinical photon beams. METHODS AND MATERIALS: Human (NCI-H460 and NCI-H2172) and murine (KLN-205 and LKR-13) lung cancer cell lines and a normal human bronchial epithelial cell line (Beas-2B) were irradiated with photons from a 6-MV linear accelerator, an 180-kVp orthovoltage unit (average energy ∼60 keV), or a system that generates 60-keV quasimonoenergetic convergent photons. Clonogenic cell survival was analyzed to assess dose-response metrics and relative biological effectiveness (RBE) in all cell lines. DNA damage and cell cycle analyses were assessed in human-derived lung cancer cell lines. A human lung cancer (NCI-H460) xenograft model was used to test tumor growth delay in vivo. RESULTS: Relative to 6-MV photons, the 60-keV quasimonoenergetic convergent and orthovoltage photons induced comparable cell kill effect and RBE for the LKR-13, KLN-205, and Beas-2B cell lines and higher cell kill effect and RBE for the NCI-H460 (significant) and NCI-H2172 (nonsignificant) cell lines. The enhanced biological response to orthovoltage and 60-keV quasimonoenergetic convergent photons in NCI-H460 cells was also evidenced by increased DNA damage signaling and cell cycle checkpoint activation. Radiosensitivity differed considerably among cell lines, even for the same radiation type. The 60-keV quasimonoenergetic convergent photons significantly delayed tumor growth, achieving effects comparable to 6-MV photons, in the NCI-H460 xenograft model. CONCLUSIONS: In vitro and in vivo evaluations confirmed that the biological effectiveness of 60-keV quasimonoenergetic convergent photons is similar to that of photons from an orthovoltage unit (average energy ∼60 keV) and either comparable (3 cell lines) or higher (2 cell lines, but 1 was not significant) than photons from a 6-MV linear accelerator.
引用
- Rai Y, Hoseini-Ghahfarokhi M, Bright SJ, et al. Radiobiological Characterization of 60-keV Quasimonoenergetic Convergent Photons. Int J Radiat Oncol Biol Phys. 2026. PMID: 42362067. doi:10.1016/j.ijrobp.2026.06.3056
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。